References

1. Control CfD, Prevention. Estimated influenza illnesses and hospitalizations averted by influenza vaccination-United States, 2012-13 influenza season. MMWR Morbidity and mortality weekly report.2013;62(49):997.
2. Sugaya N, Shinjoh M, Nakata Y, et al. Three-season effectiveness of inactivated influenza vaccine in preventing influenza illness and hospitalization in children in Japan, 2013–2016. Vaccine.2018;36(8):1063-1071.
3. Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Archives of internal medicine. 2000;160(21):3243-3247.
4. Eccles R. Understanding the symptoms of the common cold and influenza. The Lancet infectious diseases. 2005;5(11):718-725.
5. Cohen AL, Hellferscee O, Pretorius M, et al. Epidemiology of influenza virus types and subtypes in South Africa, 2009–2012.Emerging infectious diseases. 2014;20(7):1162.
6. Wagner R, Matrosovich M, Klenk HD. Functional balance between haemagglutinin and neuraminidase in influenza virus infections.Reviews in medical virology. 2002;12(3):159-166.
7. Yang H, Carney PJ, Mishin VP, et al. The molecular characterizations of surface proteins hemagglutinin and neuraminidase from recent H5Nx avian influenza viruses. Journal of virology. 2016:JVI. 00180-00116.
8. Kallewaard NL, Corti D, Collins PJ, et al. Structure and function analysis of an antibody recognizing all influenza A subtypes.Cell. 2016;166(3):596-608.
9. Paul Glezen W, Schmier JK, Kuehn CM, Ryan KJ, Oxford J. The burden of influenza B: a structured literature review. American journal of public health. 2013;103(3):e43-e51.
10. Irving SA, Patel DC, Kieke BA, et al. Comparison of clinical features and outcomes of medically attended influenza A and influenza B in a defined population over four seasons: 2004–2005 through 2007–2008. Influenza and other respiratory viruses.2012;6(1):37-43.
11. Clark NM, Lynch JP. Influenza: epidemiology, clinical features, therapy, and prevention. Paper presented at: Seminars in respiratory and critical care medicine2011.
12. Olson DR, Heffernan RT, Paladini M, Konty K, Weiss D, Mostashari F. Monitoring the impact of influenza by age: emergency department fever and respiratory complaint surveillance in New York City. PLoS Medicine. 2007;4(8):e247.
13. Marchiori E, Zanetti G, Fontes CAP, et al. Influenza A (H1N1) virus-associated pneumonia: High-resolution computed tomography–pathologic correlation. European journal of radiology. 2011;80(3):e500-e504.
14. Nicolini A, Ferrera L, Rao F, Senarega R, Ferrari-Bravo M. Chest radiological findings of influenza A H1N1 pneumonia. Revista Portuguesa de Pneumologia (English Edition). 2012;18(3):120-127.
15. Agarwal PP, Cinti S, Kazerooni EA. Chest radiographic and CT findings in novel swine-origin influenza A (H1N1) virus (S-OIV) infection. American Journal of Roentgenology.2009;193(6):1488-1493.
16. Ajlan AM, Quiney B, Nicolaou S, Muller NL. Swine-origin influenza A (H1N1) viral infection: radiographic and CT findings. American Journal of Roentgenology. 2009;193(6):1494-1499.
17. Rostami M, Javadi A-A, Khorvash F, et al. Thoracic computerized tomographic (CT) findings in 2009 influenza A (H1N1) virus infection in Isfahan, Iran. Journal of research in medical sciences: the official journal of Isfahan University of Medical Sciences.2011;16(5):591.
18. Elicker BM, Schwartz BS, Liu C, et al. Thoracic CT findings of novel influenza A (H1N1) infection in immunocompromised patients.Emergency radiology. 2010;17(4):299-307.
19. Walsh EE, Cox C, Falsey AR. Clinical features of influenza A virus infection in older hospitalized persons. Journal of the American Geriatrics Society. 2002;50(9):1498-1503.
20. Cao B, Li X-W, Mao Y, et al. Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. New England Journal of Medicine. 2009;361(26):2507-2517.
21. Hu J, Kao C, Lee P, et al. Clinical features of influenza A and B in children and association with myositis. JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION. 2004;37(2):95.
22. Calitri C, Gabiano C, Garazzino S, et al. Clinical features of hospitalised children with 2009 H1N1 influenza virus infection.European journal of pediatrics. 2010;169(12):1511-1515.
23. Plessa E, Diakakis P, Gardelis J, Thirios A, Koletsi P, Falagas ME. Clinical features, risk factors, and complications among pediatric patients with pandemic influenza A (H1N1). Clinical pediatrics.2010;49(8):777-781.
24. Kaji M, Watanabe A, Aizawa H. Differences in clinical features between influenza A H1N1, A H3N2, and B in adult patients.Respirology. 2003;8(2):231-233.
25. McDade TW, Borja JB, Kuzawa CW, Perez TLL, Adair LS. C-reactive protein response to influenza vaccination as a model of mild inflammatory stimulation in the Philippines. Vaccine.2015;33(17):2004-2008.
26. Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ. C-reactive protein and the risk of incident colorectal cancer. Jama.2004;291(5):585-590.
27. Morton B, Nweze K, O’connor J, et al. Oxygen exchange and C-reactive protein predict safe discharge in patients with H1N1 influenza.QJM: An International Journal of Medicine. 2017;110(4):227-232.
28. Li W, Luo S, Zhu Y, Wen Y, Shu M, Wan C. C‐reactive protein concentrations can help to determine which febrile infants under three months should receive blood cultures during influenza seasons.Acta Paediatrica. 2017;106(12):2017-2024.
29. Wiwanitkit V. H7N9 influenza-the laboratory presentations: a letter to editor. Asian Pac J Trop Biomed. 2013;3(7):584-585.
30. Soleimani G, Akbarpour M. Clinical presentation of novel influenza A (H1N1) in hospitalized children. Iranian journal of pediatrics.2011;21(2):215.